Corporate Responsibility

Sarepta’s cultural values, the foundational behaviors that support the way we operate, embed our shared commitment to inclusivity in our day-to-day actions. At Sarepta, we value diverse and innovative self-starters who are committed to excellence and improving the lives of our patients.

We are committed to ensuring our innovations reach as many patients as possible, as quickly as possible. We believe it is our responsibility to act as a true partner with patient communities, both in the near- and long-term.

SareptAssist is a patient support program designed to provide individuals with the information to navigate the process of starting and staying on therapy. This program is for individuals residing in the United States who are eligible for treatment with a Sarepta product.

We have dedicated professionals who make up our global Patient Affairs team. They work every day to ensure the patient voice is incorporated into our work. We regularly engage with the patient community through informational webinars, awareness and fundraising events such as community walks/runs and through ongoing dialogue at advocacy and scientific conferences around the globe. Throughout our global offices, annual recognition of Rare Disease Day, Duchenne Action Month, Duchenne Awareness Day, Limb-girdle muscular dystrophy Awareness Day and several other awareness events are opportunities for our passionate team to demonstrate a shared commitment to the individuals and patients we aim to serve.  

The patient voice is also an important and regular aspect of our quarterly All Employee Meetings. We frequently invite a patient or member of the community to speak and spend part of the day with us. We’ve instituted robust philanthropic initiatives, including a Grants & Donations program, Sponsorships, Fellowships, Investigator-Initiated Studies, and Medical Education Grants. In 2018, we launched our first scholarship program designed to help defray the cost of higher education for individuals living with Duchenne muscular dystrophy.

As part of our commitment to equity, data integrity, and scientific leadership, Sarepta continues to promote diversity, equity, and inclusion (DEI) for our employees and patient communities. We are working towards breaking the demographic, socio-economic, and geographical barriers to accessing scientific/educational information, participation in clinical trials, and treatment. Specific actions and accomplishments to date include: convening an internal, executive-sponsored task force, PEACE (Patient Equity and Access Cross-functional Exchange), to map and measure our progress organization-wide, designing a DEI-focused virtual learning module for investigative sites, and partnering with patient advocacy groups. As we continue to explore what patient equity and access mean at Sarepta, we believe that clinical trial diversity is essential to our overall mission of engineering precision genetic medicine for rare diseases that devastate lives and cut futures short.

At Sarepta, we strive to foster an environment where everyone can thrive. We are committed to building a culture that is diverse and promotes a sense of belonging, equity and personal and professional development across the organization. In the area of gender diversity, representation of women has increased over the past several years: in 2017 and 2018, women made up approximately half of our workforce, in 2019 this percentage totaled 54%, in 2020 it reached 55%, in 2021 the percentage increased to 56% and in 2022 it increased further to 57%. In 2017, women represented 35% of the leadership positions at the Director level and above. This percentage increased to 36% in 2018, remained at 44% in 2019 and 2020, increased to 48% in 2021 and in 2022 reached 52%. Our commitment to gender diversity is also reflected in our Board composition where in 2021, women held 29% of the Board seats, including the Chair of the Board. 

The number of employees identifying as people of color* has also increased from 23% of our workforce in 2017 and 2018, to 26% in 2019. In 2020 and 2021, that number remained at 30% and increased to 34% in 2022. In 2017, employees identifying as people of color represented 21% of leadership positions at the Director level and above, increasing to 25% in 2018 and 2019. The percentage further increased to 28% in 2020 and decreased in 2021 to 25% and remained at 25% for 2022. Our Executive Committee, which represents the most senior leadership positions in the Company, is 63% diverse based on gender and ethnicity.

^{*People or Person of Color (POC) - includes Asian, Black, Indigenous, Middle Eastern, Pacific Islander, multi-racial, Hispanic/Latinx and other non-white populations.}

We have five Employee Resource Groups (ERGs) that aim to foster an environment where all of our colleagues feel valued for their unique perspectives and are empowered to contribute to the success of our organization and their personal career growth. As of December 2020, more than half of our colleagues participate as active members of an ERG.

• Pride – Our ERG for employees who identify as LBGTQ along with their allies provides members with a forum to promote a dynamic, welcoming, and friendly atmosphere while strengthening diversity and inclusion at Sarepta. 
• Spark - Fuels employee career growth and development to cultivate future industry leaders through networking and mentoring opportunities and forming meaningful connections within Sarepta and our broader community.
• Sarepta Women’s Alliance provides a community of support to facilitate the development of women within Sarepta by providing leadership opportunities to grow and develop talented, engaged leaders who represent and reinforce the mission and vision of Sarepta.
• Sarepta’s Multicultural Employee Resource Group (M-ERG) was created to embrace, promote and celebrate Sarepta’s cultural diversity and to foster a culture of inclusion and appreciation for employees of varied backgrounds.
• HUES aims to attract, retain, and facilitate the development of Black employees by providing opportunities to grow and develop talented, engaged leaders who represent and reinforce the mission and vision of Sarepta. HUES also fosters and engages Black students in various communities to provide exposure to Sarepta and the sciences.

We are committed to our employees and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture of wellness and development through a variety of programs:

• In recognition of the ongoing challenges brought on by the COVID-19 pandemic, we took various steps to support our employees, including transitioning to remote/hybrid work and offering flexible schedules, childcare assistance and sessions focused on resilience and happiness in uncertain times.
• Comprehensive employee health and life insurance benefits
• Employee Assistance Program (EAP) and various mental wellness resources
• Work-Life programming to help employees integrate home and work life
• Tuition Reimbursement
• Subsidized commuter benefit
• Fitness subsidies
• Sarepta Strong Fitness Group 
• Company-wide "Let’s Go" movement and activity competitions
• Robust offering of learning opportunities for employees at every stage in their career

We are also committed to ensuring our employees receive the training needed to excel in their roles and achieve our mission, including trainings related to:

• Our Code of Conduct and Business Ethics on topics such as anti-corruption, bribery, anti-harassment and insider trading laws
• Cybersecurity 
• Industry-compliant interactions with healthcare professionals and marketing and promotion practices
• Product safety and complaints, including quarterly management reviews

In support of our employees’ continued growth and ongoing success, we have a global goal-setting and development planning process and seek to promote a culture of continuous learning through the programs below: 

• Sarepta University: A comprehensive learning resource housing leadership, professional skills, compliance and quality, as well as therapy and disease-state knowledge
• GT-IQ: A series of gene therapy-focused educational initiatives and learning materials  
• Additional opportunities for learning include frequent presentations by guest speakers from the patient and research communities, regular R&D-hosted Lunch-and-Learns, GxP Webinars and a Spice-Up-Your-Knowledge lunch time series hosted by our Quality Control team at our Andover facility

In addition to supporting the health, wellness and professional development of our employees, we are committed to providing safe working conditions through our Employee Health and Safety program, key components of which include:

• Adapting to the evolving challenges of the COVID-19 pandemic and protecting our facility-dependent employees, including those needed to maintain manufacturing and clinical research, by instituting strict protocols designed to ensure they remain healthy and feel supported and safe in our facilities;
• Regular health and safety training for all employees, including lab-specific trainings;
• Formal protocols for emergency preparedness;
• Actively engaging employees for hazard identification, risk assessments and monthly lab inspections; and
• Ongoing monitoring and data collection to reduce health and safety incidents, and developing reduction targets. 

The health of our planet and the health of humanity are inextricably linked. At Sarepta Therapeutics, we believe in doing our part in supporting the health of the communities in which we live and work and are dedicated to protecting the health and safety of our employees, as we pursue our mission of developing precision genetic medicines for individuals living with rare disease. 

Our Dedication to Health & Safety: Sarepta Therapeutics maintains a healthy and safe work environment for its employees by providing a harm-free workplace. Employee health and safety efforts are centered on education, training and awareness, and our policies are centered around personal accountability and the ability to identify risks. As an organization dedicated to employee health and safety, our executive leadership team prioritizes all matters related to health and safety, acting to mitigate risks and identify opportunities for improvement. 

Our Commitment to Environmental Stewardship: The impact of climate change is far reaching, including posing short-term and long-term risks to our employees and the patients we serve. We understand that energy, water, and materials use; greenhouse gas emissions; material and hazardous waste; and transportation are among the largest contributors to our environmental footprint. As our business continues to grow, we will continue to recognize the importance of understanding, mitigating, and reporting our environmental footprint. 

Our EHS Policy in Practice: Sarepta Therapeutics will comply with all applicable EHS regulations and company standards. This EHS Policy is communicated to employees from the start of employment during an EHS Orientation and continually thereafter. All employees and contractors must comply with this EHS policy and applicable EHS programs and follow role specific training curricula. Employees and contractors must act in a manner that protects themselves, their colleagues, the community, and the environment.

Sarepta has a responsibility and is eager to protect our environment. We understand the connection between the health of our planet and the health of humanity. The impacts of climate change are far reaching, including short-term and long-term risks to human health. Our mission will always be delivering precision genetic medicines with urgency to our patients, but we recognize opportunities to do our part in creating a healthy environment for patients, our people and communities. 

We have a responsibility to protect our environment and understand that individual actions make a difference. We are committed to being environmentally responsible members of the community and support our people in that effort as well. To further these efforts we sponsor the following programs:

Commuting:

• Green/sustainable commuter benefits including fully subsidized public transportation
• Flexible work arrangements including remote work and hybrid work
• Electric vehicle charging stations at Andover, MA, Burlington, MA and Cambridge, MA sites
• Bike Share discounts

Facilities and lab space:

• Nighttime and weekend setback programs for lighting and heat at most of Sarepta’s sites and all of our labs
• Established green lab initiatives in order to reduce waste, opting for reusable materials when possible  
• Companywide re-lamping program to replace Compact fluorescent and Metal halide bulbs with LEDs in office spaces and the Andover, MA site parking lot
• Companywide recycling programs for paper, batteries, lab glass and electronic waste
• Single stream recycling at Andover, MA site
• Established sustainability committee for Ohio-based labs with the goal of expanding the program to all Sarepta labs
• Burlington, MA lab site is LEED certified space